logo

NIAMS Clinical Study Implementation Cooperative Agreement (UM1)

Sector: Hospital • Location: United States of America

Source: Grants.gov

Project
Archived

This Funding Opportunity Announcement (FOA) issued by the NIAMS invites cooperative agreement (UM1) applications for implementation of investigator-initiated interventional clinical trials (all phases). Applications for clinical trials submitted to the NIAMS are normally expected to go through a two-part process, which begins with a (U34) planning phase (Part 1) followed by an application for the

Project Information FAQ

Project Information

4 Q
The project “NIAMS Clinical Study Implementation Cooperative Agreement (UM1)” is an infrastructure initiative in the Hospital sector, located in United States of America. Taiyo aggregates data on it from Grants.gov.

Want to explore the full details? View the full report

Participants

Sponsoring Agency

Obfuscated Data

Company

Obfuscated Data

Status

Original status

archived

Taiyo status

Obfuscated Data

Taiyo last update

00-00-0000

Available timestamps

00-00-0000

Available timestamp type

Obfuscated Data

Contact

Contact name

Obfuscated Data

Phone

0000000000

Email

ObfuscatedData@email.com

Address

Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Description

Description

This Funding Opportunity Announcement (FOA) issued by the NIAMS invites cooperative agreement (UM1) applications for implementation of investigator-initiated interventional clinical trials (all phases). Applications for clinical trials submitted to the NIAMS are normally expected to go through a two-part process, which begins with a (U34) planning phase (Part 1) followed by an application for the (UM1) clinical trial implementation phase (Part 2). See PAR-11-169 for information about the NIAMS Clinical Trial Planning Cooperative Agreement (U34). Investigators who have completed all necessary pre-trial planning and preparation through other means may also apply for a NIAMS UM1. Consultation with NIAMS staff is strongly encouraged prior to the submission of the clinical trial implementation UM1 application. The NIAMS expects such trials to be hypothesis-driven, milestone-defined, related to the research mission of the NIAMS, and considered high priority by the Institute.

Original sub-sector

Obfuscated

Original Currency

USD

Original budget

000000000000000

Procurement method

Obfuscated Data

Budget

000000000000000

Location

Region

Obfuscated

Country

Obfuscated

State

Obfuscated Data

County

Obfuscated

Location

Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data

Source

Source reliability

High

Data quality score

100%

Source

Obfuscated Data

URL

obfuscated_data,obfuscateddata.com

More Details

Project Type

Obfuscated Data

Article Published Date

Obfuscated Data